A large cohort study found no increased risk of suicidality among type 2 diabetes patients using GLP-1 receptor agonists compared to DPP-4 or SGLT-2 inhibitors after adjusting for confounders.
Americans report record-low mental and physical health assessments in Gallup survey, with young women experiencing steepest mental health decline since the COVID-19 pandemic began despite end of public health emergency.